PL352374A1 - Inhibitors of integrine o v beta 6 - Google Patents

Inhibitors of integrine o v beta 6

Info

Publication number
PL352374A1
PL352374A1 PL00352374A PL35237400A PL352374A1 PL 352374 A1 PL352374 A1 PL 352374A1 PL 00352374 A PL00352374 A PL 00352374A PL 35237400 A PL35237400 A PL 35237400A PL 352374 A1 PL352374 A1 PL 352374A1
Authority
PL
Poland
Prior art keywords
integrine
inhibitors
beta
Prior art date
Application number
PL00352374A
Other languages
English (en)
Inventor
Alfred Jonczyk
Beate Diefenbach
Ulrich Groth
Gunther Zischinsky
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of PL352374A1 publication Critical patent/PL352374A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
PL00352374A 1999-06-26 2000-06-13 Inhibitors of integrine o v beta 6 PL352374A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19929410A DE19929410A1 (de) 1999-06-26 1999-06-26 Inhibitoren des Integrins avß6
PCT/EP2000/005404 WO2001000660A1 (de) 1999-06-26 2000-06-13 INHIBITOREN DES INTEGRINS αv$(g)b¿6?

Publications (1)

Publication Number Publication Date
PL352374A1 true PL352374A1 (en) 2003-08-25

Family

ID=7912712

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00352374A PL352374A1 (en) 1999-06-26 2000-06-13 Inhibitors of integrine o v beta 6

Country Status (17)

Country Link
EP (1) EP1189930A1 (xx)
JP (1) JP2003503422A (xx)
KR (1) KR20020015704A (xx)
CN (1) CN1358195A (xx)
AR (1) AR024472A1 (xx)
AU (1) AU771099B2 (xx)
BR (1) BR0011954A (xx)
CA (1) CA2377224A1 (xx)
CZ (1) CZ20014484A3 (xx)
DE (1) DE19929410A1 (xx)
HU (1) HUP0201729A3 (xx)
MX (1) MXPA01013247A (xx)
NO (1) NO20016341L (xx)
PL (1) PL352374A1 (xx)
SK (1) SK18722001A3 (xx)
WO (1) WO2001000660A1 (xx)
ZA (1) ZA200200673B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6972296B2 (en) 1999-05-07 2005-12-06 Encysive Pharmaceuticals Inc. Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
AU2004208865B2 (en) 2003-02-06 2010-06-17 Merck Patent Gmbh Peptidic sulfonamides
GB0520068D0 (en) 2005-10-03 2005-11-09 Cancer Res Technology av peptide ligand
KR20090039739A (ko) 2006-08-03 2009-04-22 아스트라제네카 아베 αＶβ６에 대해 작용하는 항체 및 그의 용도
KR102634762B1 (ko) * 2016-11-01 2024-02-06 애로우헤드 파마슈티컬스 인코포레이티드 알파-v 베타-6 인테그린 리간드 및 그의 용도
KR20200083523A (ko) 2017-11-01 2020-07-08 애로우헤드 파마슈티컬스 인코포레이티드 인테그린 리간드 및 그의 용도

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2103139A1 (en) * 1991-05-14 1992-11-15 George A. Heavner Peptide inhibitors of inflammation
US20020004482A1 (en) * 1997-08-08 2002-01-10 Xiaozhu Huang Treatment of acute lung injury and fibrosis with antagonists of avbeta6
CN1335853A (zh) * 1998-12-19 2002-02-13 默克专利股份公司 整联蛋白αvβb的抑制剂

Also Published As

Publication number Publication date
JP2003503422A (ja) 2003-01-28
DE19929410A1 (de) 2000-12-28
ZA200200673B (en) 2003-04-24
CA2377224A1 (en) 2001-01-04
SK18722001A3 (sk) 2002-05-09
CZ20014484A3 (cs) 2002-04-17
HUP0201729A2 (en) 2002-08-28
NO20016341L (no) 2002-02-25
CN1358195A (zh) 2002-07-10
HUP0201729A3 (en) 2005-01-28
AU6263000A (en) 2001-01-31
KR20020015704A (ko) 2002-02-28
WO2001000660A1 (de) 2001-01-04
AR024472A1 (es) 2002-10-02
BR0011954A (pt) 2002-05-07
EP1189930A1 (de) 2002-03-27
AU771099B2 (en) 2004-03-11
NO20016341D0 (no) 2001-12-21
MXPA01013247A (es) 2002-07-02

Similar Documents

Publication Publication Date Title
IL141445A0 (en) Benzazine derivatives as phosphodiesterase 4 inhibitors
EG24291A (en) Novel form of s-omeprazole
GB9900416D0 (en) Inhibitors
PL334846A1 (en) Sulphamidic inhibitors of metaloproteases
ZA98376B (en) Sulfamide-metalloprotease inhibitors
GB0024805D0 (en) Amide derivatives as beta 3 agonists
PL335378A1 (en) Derivatives of inverse hydroxamates as metaloprotease inhibitors
PL337827A1 (en) Bactericidal derivatives of n-sulphoglycin alkynyloxyphenethylamide
HK1039124B (zh) 二氮雜萘衍生物磷酸二酯酶4抑制劑
PL339176A1 (en) Derivatives of pyrrolopyrrolone as inhibitors of neutrophilic elastase
IL141446A0 (en) Benzazine derivatives as phosphodiesterase 4 inhibitors
EP1093373A4 (en) OLIGONUCLEOTIDES INHIBITORS OF bcl-xL
HK1042695A1 (zh) 蛋白酶抑制劑
PL352374A1 (en) Inhibitors of integrine o v beta 6
PL339186A1 (en) Derivatives of pyrrolopyrrolone as inhibitors of neutrophilic elastase
PL352409A1 (en) Derivatives of 1-trifluorometyl-4-hydroxy-7-piperidinyl-aminomethylochromane
PL350963A1 (en) Use of arylalkanoylpyridazines
HK1051033A1 (zh) 白細胞介素5基因表達抑制劑
HUP0201610A2 (en) Derivatives of 4'-demycarosyl-8a-aza-8a-homotylosin
GB9904070D0 (en) Inhibition of scale
GB9827817D0 (en) Type 11 Dehydroquinase inhibitors
AU143545S (en) Set of screws
HU9900075V0 (en) Sepulchre consists of elements
GB9929341D0 (en) Inhibitors
GB9929340D0 (en) Inhibitors